RUA — Rua Bioscience Cashflow Statement
0.000.00%
- NZ$11.77m
- NZ$12.99m
- NZ$2.58m
Annual cashflow statement for Rua Bioscience, fiscal year end - June 30th, NZD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.696 | 0.104 | 0.755 | 0.268 | 0.244 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.84 | -5.92 | -3.74 | -2.79 | -2.96 |
| Capital Expenditures | -0.4 | -0.074 | -0.001 | -0.003 | -0.002 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 5.99 | 6.75 | 2.21 | 0.109 | 0.007 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 5.59 | 6.67 | 2.21 | 0.106 | 0.006 |
| Financing Cash Flow Items | -0.045 | -0.019 | -0.017 | -0.175 | -0.372 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.209 | -0.12 | -0.095 | 2.02 | 3.24 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.46 | 0.632 | -1.63 | -0.654 | 0.292 |